Treatment and outcome of the 35 patients with MALT-SS.
| Treatment | N | Stage | Initial High SS Disease Activity | Total | Outcome | ||
|---|---|---|---|---|---|---|---|
| CR | PR | SD | |||||
| Watchful waiting | 10 | L | 0 | 9 | 0 | 0 | 9 |
| LD | 1 | 1 | 0 | 0 | 1 | ||
| DD | 0 | 0 | 0 | 0 | 0 | ||
| Surgery | 3 | L | 0 | 1 | 1 | 0 | 0 |
| LD | 0 | 1 | 0 | 0 | 1 | ||
| DD | 0 | 1 | 0 | 0 | 1 | ||
| Radiotherapy | 1 | LD | 1 | 1 | 0 | 0 | 1 |
| Surgery/radiotherapy | 2 | L | 0 | 1 | 1 | 0 | 0 |
| LD | 0 | 0 | 0 | 0 | 0 | ||
| DD | 0 | 1 | 1 | 0 | 0 | ||
| Rituximab | 13 | L | 1 | 11 | 3 | 1 | 7 |
| LD | 2 | 2 | 2 | 0 | 0 | ||
| DD | 0 | 0 | 0 | 0 | 0 | ||
| R-CP | 6 | L | 0 | 4 | 4 | 0 | 0 |
| LD | 0 | 0 | 0 | 0 | 0 | ||
| DD | 2 | 2 | 2 | 0 | 0 | ||
| Total | 35 | 7 | 35 | 14 | 1 | 20 | |
L: localized disease; LD: locally disseminated disease; DD: disseminated disease; CR: complete remission; PR: partial response; SD: stable disease; R-CP: rituximab-cyclophosphamide-prednisone combination.